Form 4: Bolt Biotherapeutics CEO Reports Stock Transaction
Insider Transaction (Form 4)
William P. Quinn, President, CEO and CFO and a Director of Bolt Biotherapeutics, Inc., reported multiple transactions in common stock on September 16, 2026.
Summary
- Open-market purchase: acquired 637 Common Stock at $3.88 ($2,469) on June 5, 2026; holds 2,950 after (Direct).
- Open-market sale: disposed of 1,889 Common Stock at $3.77 ($7,129) on September 16, 2026; holds 41,061 after (Direct).
- Open-market sale: disposed of 6,545 Common Stock at $3.32 ($21,718) on September 17, 2026; holds 34,516 after (Direct).
- Open-market sale: disposed of 9,132 Common Stock at $3.24 ($29,555) on September 18, 2026; holds 25,384 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai notes net insider selling of $55,933 across mixed open-market transactions.
Insider Transactions
William P. Quinn — Director, Officer (President, CEO and CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-05 | Open-market purchase | Common Stock | 637 | $4 | $2.5K | 2,950 |
| 2026-09-16 | Open-market sale | Common Stock | 1,889 | $4 | $7.1K | 41,061 |
| 2026-09-17 | Open-market sale | Common Stock | 6,545 | $3 | $21.7K | 34,516 |
| 2026-09-18 | Open-market sale | Common Stock | 9,132 | $3 | $29.6K | 25,384 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-05 | Open-market purchase (637 shares) |
| 2026-09-16 | Open-market sale (1,889 shares) |
| 2026-09-17 | Open-market sale (6,545 shares) |
| 2026-09-18 | Open-market sale (9,132 shares) |
Keywords
insider transaction, Form 4, BOLT, Bolt Biotherapeutics, Inc., net selling, William P. Quinn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.